Effect of Vasopressin V1b Receptor Blockade on Activity of the Hypothalamic-Pituitary-Adrenal Axis in Old Monkeys with Depression-Like and Anxious Behavior Subjected to Stress or Injected with Vasopressin
- PMID: 30450521
- DOI: 10.1007/s10517-018-4294-4
Effect of Vasopressin V1b Receptor Blockade on Activity of the Hypothalamic-Pituitary-Adrenal Axis in Old Monkeys with Depression-Like and Anxious Behavior Subjected to Stress or Injected with Vasopressin
Abstract
The effect of selective antagonist of the arginine vasopressin (AVP) V1b receptors on the secretion of ACTH and corticosteroids in response to insulin-induced hypoglycemia and injection of AVP is studied in old Macaca mulatta females with depression-like and anxious behavior. Intravenous antagonist in a dose of 1.1-1.7 μg/kg inhibits the increase of ACTH concentration, induced by hypoglycemia or injection of AVP. The degree of increase in the concentrations of hydrocortisone and dehydroepiandrosterone sulfate has not changed or increased. The effects of AVP antagonist prove that previously detected disorders in the reaction of the hypothalamic-pituitary-adrenal system in old Macaca mulatta with depression-like and anxious behavior could be caused by excessive activation of vasopressin V1b receptors on the pituitary corticotrophs, while the use of V1b receptor antagonists seems to be a promising method for prevention of these disorders.
Keywords: depression-like and anxious behavior; hypothalamic—pituitary—adrenal axis; old Macaca mulatta; stress; vasopressin V1b receptor antagonist.
Similar articles
-
Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.Psychopharmacology (Berl). 2016 Jan;233(1):71-81. doi: 10.1007/s00213-015-4089-5. Epub 2015 Sep 26. Psychopharmacology (Berl). 2016. PMID: 26407603 Clinical Trial.
-
Age-specific and individual features of vasopressinergic regulation of the hypothalamic-pituitary-adrenal system in primates.Bull Exp Biol Med. 2015 Apr;158(6):804-6. doi: 10.1007/s10517-015-2866-0. Epub 2015 Apr 21. Bull Exp Biol Med. 2015. PMID: 25894781
-
The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.J Clin Invest. 2004 Jan;113(2):302-9. doi: 10.1172/JCI19656. J Clin Invest. 2004. PMID: 14722621 Free PMC article.
-
Evidence for the contribution of vasopressin V1B receptors in the pathophysiology of depression.Biochem Pharmacol. 2025 Jan;231:116672. doi: 10.1016/j.bcp.2024.116672. Epub 2024 Nov 26. Biochem Pharmacol. 2025. PMID: 39608503 Review.
-
Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation.Regul Pept. 2000 Dec 22;96(1-2):23-9. doi: 10.1016/s0167-0115(00)00196-8. Regul Pept. 2000. PMID: 11102648 Review.
Cited by
-
Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study.Front Psychiatry. 2020 May 20;11:453. doi: 10.3389/fpsyt.2020.00453. eCollection 2020. Front Psychiatry. 2020. PMID: 32508691 Free PMC article.
-
Glucocorticoid Negative Feedback in Regulation of the Hypothalamic-Pituitary-Adrenal Axis in Rhesus Monkeys With Various Types of Adaptive Behavior: Individual and Age-Related Differences.Front Endocrinol (Lausanne). 2019 Feb 13;10:24. doi: 10.3389/fendo.2019.00024. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30814974 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous